E-LIB Suche - Ergebnisse für: Shoukier, Mahran

1

Treatment patterns and outcomes of high-grade immune checkp..:

Manzano, Joanna-Grace M. ; Sahar, Hadeel ; Aldrich, Jeffrey...
Supportive Care in Cancer. 32 (2024) 3 - p. , 2024

2

Blood Product Support in Multiple Myeloma Patients Undergoi..:

Pavkov, Isabela L ; Shoukier, Mahran ; Mian, Mohammad AH...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S393 , 2024

Link: https://doi.org/10.1016/..

3

Industry's role in HIV, hepatitis B, and hepatitis C exclus..:

Anwar, Tahsin ; Malhotra, Sean ; Mian, Mohammad A. H....
Hematology. 28 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

4

A Phase I Study of the Non-Receptor Kinase Inhibitor Bosuti..:

Karim, Nagla Abdel ; Ullah, Asad ; Wang, Hongkun...
Current Oncology. 29 (2022) 12 - p. 9461-9473 , 2022

Link: https://doi.org/10.3390/..

5

Activity of decitabine as maintenance therapy in core bindi..:

Senapati, Jayastu ; Shoukier, Mahran ; Garcia‐Manero, Guillermo...
American Journal of Hematology. 97 (2022) 5 - p. 574-582 , 2022

Link: https://doi.org/10.1002/..

6

Poster: IBCL-015 The Financial Toxicity of FDA-Drugs Approv..:

Shoukier, Mahran ; Casey, Mycal ; Cortes, Jorge
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S173 , 2022

Link: https://doi.org/10.1016/..

7

IBCL-015 The Financial Toxicity of FDA-Drugs Approved for M..:

Shoukier, Mahran ; Casey, Mycal ; Cortes, Jorge
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S383 , 2022

Link: https://doi.org/10.1016/..

8

Outcomes in patients with newly diagnosed TP53‐mutated acut..:

Venugopal, Sangeetha ; Shoukier, Mahran ; Konopleva, Marina...
Cancer. 127 (2021) 19 - p. 3541-3551 , 2021

Link: https://doi.org/10.1002/..

9

Inflammatory Myositis in Cancer Patients Receiving Immune C..:

Aldrich, Jeffrey ; Pundole, Xerxes ; Tummala, Sudhakar...
Arthritis & Rheumatology. 73 (2021) 5 - p. 866-874 , 2021

Link: https://doi.org/10.1002/..

10

Sudden Blast Crisis After Excellent Initial Response in Chr..:

Vijaya Prakash, Aviraag ; Sivakolundu, Keerthana P ; Savage, Natasha M..
Cureus. , 2021

Link: https://doi.org/10.7759/..

11

AML-468: Outcomes of FLT3-Mutated Acute Myeloid Leukemia Pa..:

Shoukier, Mahran ; Kota, Vamsi ; Jillella, Ravindra..
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S313 , 2021

Link: https://doi.org/10.1016/..

12

Post-transplantation cyclophosphamide reduces the incidence..:

Saberian, Chantal ; Abdel-Wahab, Noha ; Abudayyeh, Ala...
Journal for ImmunoTherapy of Cancer. 9 (2021) 2 - p. e001818 , 2021

Link: https://doi.org/10.1136/..

13

Review of New-Generation Tyrosine Kinase Inhibitors for Chr..:

Shoukier, Mahran ; Kubiak, Michal ; Cortes, Jorge
Current Oncology Reports. 23 (2021) 8 - p. , 2021

Link: https://doi.org/10.1007/..

14

Poster: AML-468: Outcomes of FLT3-Mutated Acute Myeloid Leu..:

Shoukier, Mahran ; Kota, Vamsi ; Jillella, Ravindra..
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S210 , 2021

Link: https://doi.org/10.1016/..

15

The clinical impact of time to response in de novo accelera..:

Ohanian, Maro ; Kantarjian, Hagop M. ; Shoukier, Mahran...
American Journal of Hematology. 95 (2020) 10 - p. 1127-1134 , 2020

Link: https://doi.org/10.1002/..